Oxidative stress parameters in patients with slow coronary flow

Advances in Therapy

Volumn 25, Issue 1, 2008, Pages 37-44

  Enli, Yasar ^a,c   Turk, Mehmet ^a   Akbay, Ramazan ^a   Evrengul, Harun ^a   Tanriverdi, Halil ^a   Kuru, Omur ^a   Seleci, Deniz ^a   Kaftan, Asuman ^a   Ozer, Oztekin ^a   Enli, Havane ^b  

^a PAMUKKALE UNIVERSITY   (Turkey)

^b Public Health Centre   (Turkey)

^c NONE   (Turkey)

Author keywords

Antioxidants; Oxygen free radicals; Slow coronary flow

Indexed keywords

CATALASE; ERYTHROCYTE SUPEROXIDE DISMUTASE; GLUTATHIONE; MALONALDEHYDE; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVASCULAR RISK; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; ENZYME BLOOD LEVEL; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS PARAMETER; PATHOGENESIS; RISK ASSESSMENT; RISK FACTOR; SLOW CORONARY ARTERY BLOOD FLOW; MIDDLE AGED; OXIDATIVE STRESS;

BLOOD FLOW VELOCITY; CORONARY CIRCULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS;

EID: 58749110901     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-008-0011-4     Document Type: Article

References (33)

1. Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries, a new angiographic finding. Am Heart J. 1972;84:66-71.
2. Pekdemir H, Cin VG, Cicek D, et al. Slow coronary flow may be a sign of diffuse atherosclerosis. Contribution of FFR and IVUS. Acta Cardiol. 2004;59:127-133.
3. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 1997;277:1775-1781.
4. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation. 1997;95:1119-1121.
5. Goel PK, Gupta SK, Agarwal A, Kapoor A. Slow coronary flow: A distinct angiographie subgroup in syndrome X. Angiology. 2001;52:507-514.
6. Beltrame JF, Turner SP, Horowitz JD. Persistence of the coronary slow flow phenomenon. Am J Cardiol. 2001;88:938.
7. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histologic evidence for small vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation. 1986;74:964-972.
8. Kurtoglu N, Akcay A, Dindar I. Usefulness of oral dipyridamole therapy for angiographic slow coronary artery flow. Am J Cardiol. 2001;87:777-779.
9. Vrints C, Herman AG. Role of the endothelium in the regulation of coronary artery tone. Acta Cardiol. 1991;46:399-418.
10. Stocker R, Keaney JF. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004;84:1381-1478.
11. Li JJ, Xu B, Li ZC, Qian J, Wei BQ. Is slow coronary flow associated with inflammation? Med Hypothesis. 2006;66:504-508.
12. Turhan H, Saydam GS, Erbay AR, et al. Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow. Int J Cardiol. 2006;108:224-230.
13. Devasagayam TP, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD. Free radicals and antioxidants in human health: Current status and future prospects. J Assoc Phys India. 2004;52:794-804.
14. Eugene AP, Husam M, Stanley LH. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med. 2000;28:1717-1725.
15. Hurst JK. Myeloperoxidase-active site structure and catalytic machanisms. In: Everse J, Everse K, Grisham MB, eds. Peroxidases in Chemistry and Biology. Boca Raton: CRC Press; 1991:37-62.
16. Kettle AJ, Winterbourn CC. Myeloperoxidase: A key regulator of neutrophil oxidant production. Redox Rep. 1997;3:3-15.
17. Hazen SL, Hsu FF, Mueller DM, Crowley JR, Heinecke JW. Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J Clin Invest. 1996;98:1283-1289.
18. Weiss SJ, Klein R, Slivka A, Wei M. Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J Clin Invest. 1982;70:598-607.
19. Schwenke DC. Antioxidants and atherogenesis. J Nutr Biochem. 1998;9:424-445.
20. Chen J, Mehta JL. Role of oxidative stress in coronary heart disease. Indian Heart J. 2004;56:163-173.
21. Kaneda H, Taguchi J, Ogasawara K, Aizawa T, Ohno M. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis. 2002;162:221-225.
22. Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: A quantitative method of assessing coronary artery flow. Circulation. 1996;93:879-888.
23. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351-358.
24. Winterbourn CC, Hawkings RE, Brian M, Carrel RW. The estimation of red cells superoxide dismutase activity. J Lab Clin Med. 1975;85:337-342.
25. Moron MS, Depierre JW, Mannervik B. Level of glutathione, glutathione reductase and glutathione-S-transferase activity in rat lung and liver. Biochem Biophys Acta. 1979;82:67-78.
26. Knight KR, Zhang B, Morrison WA, Stewart AG. Ischaemia-referfusion injury in mouse skeletal muscle is reduced by N-nitro-L-arginine methyl ester and dexamethasone. Eur J Pharmacol. 1997;332:273-278.
27. Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121-126.
28. Baskol G, Demir H, Baskol M, et al. Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis. Clin Biochem. 2005;38:951-955.
29. Akca T, Canbaz H, Tataroglu C, et al. The effect of N-acetylcysteine on pulmonary lipid peroxidation and tissue damage. J Surg Res. 2005;129:38-45.
30. Yu BP. Cellular defenses against damage from reactive oxygen species. Phys Rev. 1994;74:139-162.
31. Erol U, Gurdal M, Erol A, Aslan R, Konukoǧlu D, Onmus H. Is midazolam effective as an antioxidant in preventing reperfusion injury in rat kidney? Int Urol Nephrol. 2002;34:121-127.
32. Bhagwat SV, Vijayasarathy C, Raza H, Mullick J, Avadhani NG. Preferential effects of nicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone on mitochondrial glutathione S-transferase a4-4 induction and increased oxidative stress in the rat brain. Biochem Pharm. 1998;56:831-839.
33. Lau D, Baldus S. Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacol Ther. 2006;111:16-26.